BF Biosciences Limited (BFB) is Pakistan’s first biopharmaceutical production facility, designed according to international standards. Karandaaz has provided BFB growth capital which will facilitate the company in the production and distribution of Remdesivir, and also result in the expansion of the facility to increase fill-and-finish capacity for vaccines to help combat COVID-19 in Pakistan. The investment will establish BFB as a leading pharma player in the country and is expected to increase job opportunities at BFB and in its supply chain.
